The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Patel, Bemal
    Director born in September 1973
    Individual (109 offsprings)
    Officer
    1999-11-26 ~ now
    OF - Director → CIF 0
  • 2
    Patel, Hital
    Company Secretary born in December 1974
    Individual (17 offsprings)
    Officer
    2006-11-28 ~ now
    OF - Director → CIF 0
    Patel, Hital
    Individual (17 offsprings)
    Officer
    1999-11-26 ~ now
    OF - Secretary → CIF 0
  • 3
    PHARMADENT HOLDINGS LIMITED
    Haslers, Old Station Road, Loughton, Essex, England
    Active Corporate (3 parents, 12 offsprings)
    Equity (Company account)
    3,751,983 GBP2024-03-31
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
Ceased 2
  • 1
    39a Leicester Road, Salford, Manchester, Lancashire
    Dissolved Corporate (2 parents, 2 offsprings)
    Officer
    1999-11-25 ~ 1999-11-25
    PE - Nominee Director → CIF 0
  • 2
    39a Leicester Road, Salford, Manchester, Lancashire
    Dissolved Corporate (2 parents, 9 offsprings)
    Officer
    1999-11-25 ~ 1999-11-25
    PE - Nominee Secretary → CIF 0
    PE - Nominee Secretary → CIF 0
parent relation
Company in focus

PHARMACEUTICALS DIRECT LIMITED

Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Average Number of Employees
222023-04-01 ~ 2024-03-31
242022-04-01 ~ 2023-03-31
Turnover/Revenue
33,644,545 GBP2023-04-01 ~ 2024-03-31
31,342,869 GBP2022-04-01 ~ 2023-03-31
Cost of Sales
-28,726,948 GBP2023-04-01 ~ 2024-03-31
-25,441,244 GBP2022-04-01 ~ 2023-03-31
Gross Profit/Loss
4,917,597 GBP2023-04-01 ~ 2024-03-31
5,901,625 GBP2022-04-01 ~ 2023-03-31
Administrative Expenses
-3,645,379 GBP2023-04-01 ~ 2024-03-31
-3,697,695 GBP2022-04-01 ~ 2023-03-31
Operating Profit/Loss
1,272,218 GBP2023-04-01 ~ 2024-03-31
2,203,930 GBP2022-04-01 ~ 2023-03-31
Other Interest Receivable/Similar Income (Finance Income)
115 GBP2022-04-01 ~ 2023-03-31
Profit/Loss on Ordinary Activities Before Tax
1,265,842 GBP2023-04-01 ~ 2024-03-31
1,953,762 GBP2022-04-01 ~ 2023-03-31
Profit/Loss
942,252 GBP2023-04-01 ~ 2024-03-31
1,581,170 GBP2022-04-01 ~ 2023-03-31
Intangible Assets
1,676 GBP2024-03-31
54,606 GBP2023-03-31
Property, Plant & Equipment
241,212 GBP2024-03-31
300,852 GBP2023-03-31
Fixed Assets - Investments
15,775,609 GBP2024-03-31
15,775,609 GBP2023-03-31
Fixed Assets
16,018,497 GBP2024-03-31
16,131,067 GBP2023-03-31
Total Inventories
4,905,610 GBP2024-03-31
6,514,193 GBP2023-03-31
Debtors
Current
27,572,229 GBP2024-03-31
28,041,878 GBP2023-03-31
Cash at bank and in hand
211,706 GBP2024-03-31
218,378 GBP2023-03-31
Current Assets
32,689,545 GBP2024-03-31
34,774,449 GBP2023-03-31
Creditors
Current, Amounts falling due within one year
-8,375,758 GBP2024-03-31
-11,515,484 GBP2023-03-31
Net Current Assets/Liabilities
24,313,787 GBP2024-03-31
23,258,965 GBP2023-03-31
Total Assets Less Current Liabilities
40,332,284 GBP2024-03-31
39,390,032 GBP2023-03-31
Net Assets/Liabilities
35,647,868 GBP2024-03-31
34,705,616 GBP2023-03-31
Equity
Called up share capital
2,079,700 GBP2024-03-31
2,079,700 GBP2023-03-31
2,079,700 GBP2022-04-01
Retained earnings (accumulated losses)
33,498,868 GBP2024-03-31
32,556,616 GBP2023-03-31
30,975,446 GBP2022-04-01
Equity
35,647,868 GBP2024-03-31
34,705,616 GBP2023-03-31
33,124,446 GBP2022-04-01
Profit/Loss
Retained earnings (accumulated losses)
942,252 GBP2023-04-01 ~ 2024-03-31
1,581,170 GBP2022-04-01 ~ 2023-03-31
Property, Plant & Equipment - Depreciation rate used
Plant and equipment
02023-04-01 ~ 2024-03-31
Motor vehicles
02023-04-01 ~ 2024-03-31
Office equipment
02023-04-01 ~ 2024-03-31
Computers
02023-04-01 ~ 2024-03-31
Audit Fees/Expenses
19,850 GBP2023-04-01 ~ 2024-03-31
19,850 GBP2022-04-01 ~ 2023-03-31
Wages/Salaries
1,669,652 GBP2023-04-01 ~ 2024-03-31
1,561,065 GBP2022-04-01 ~ 2023-03-31
Social Security Costs
118,373 GBP2023-04-01 ~ 2024-03-31
119,044 GBP2022-04-01 ~ 2023-03-31
Staff Costs/Employee Benefits Expense
1,800,636 GBP2023-04-01 ~ 2024-03-31
1,693,658 GBP2022-04-01 ~ 2023-03-31
Director Remuneration
46,122 GBP2023-04-01 ~ 2024-03-31
41,044 GBP2022-04-01 ~ 2023-03-31
Tax Expense/Credit at Applicable Tax Rate
316,461 GBP2023-04-01 ~ 2024-03-31
371,215 GBP2022-04-01 ~ 2023-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
140,189 GBP2024-03-31
140,189 GBP2023-03-31
Motor vehicles
255,285 GBP2024-03-31
255,285 GBP2023-03-31
Office equipment
543,473 GBP2024-03-31
543,473 GBP2023-03-31
Computers
16,109 GBP2024-03-31
16,109 GBP2023-03-31
Property, Plant & Equipment - Gross Cost
955,056 GBP2024-03-31
955,056 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
57,409 GBP2023-03-31
Motor vehicles
136,964 GBP2023-03-31
Office equipment
444,055 GBP2023-03-31
Computers
15,776 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
654,204 GBP2023-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment, Owned/Freehold
7,588 GBP2023-04-01 ~ 2024-03-31
Motor vehicles, Owned/Freehold
27,115 GBP2023-04-01 ~ 2024-03-31
Office equipment, Owned/Freehold
24,854 GBP2023-04-01 ~ 2024-03-31
Computers, Owned/Freehold
83 GBP2023-04-01 ~ 2024-03-31
Owned/Freehold
59,640 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
64,997 GBP2024-03-31
Motor vehicles
164,079 GBP2024-03-31
Office equipment
468,909 GBP2024-03-31
Computers
15,859 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
713,844 GBP2024-03-31
Property, Plant & Equipment
Plant and equipment
75,192 GBP2024-03-31
82,780 GBP2023-03-31
Motor vehicles
91,206 GBP2024-03-31
118,321 GBP2023-03-31
Office equipment
74,564 GBP2024-03-31
99,418 GBP2023-03-31
Computers
250 GBP2024-03-31
333 GBP2023-03-31
Investments in Subsidiaries
100 GBP2024-03-31
100 GBP2023-03-31
Finished Goods/Goods for Resale
4,905,610 GBP2024-03-31
6,514,193 GBP2023-03-31
Amounts Owed by Group Undertakings
Current
19,521,341 GBP2024-03-31
19,876,448 GBP2023-03-31
Other Debtors
Current
3,226,750 GBP2024-03-31
2,892,727 GBP2023-03-31
Prepayments/Accrued Income
Current
32,197 GBP2024-03-31
32,197 GBP2023-03-31
Bank Overdrafts
-55 GBP2023-03-31
Cash and Cash Equivalents
211,706 GBP2024-03-31
218,323 GBP2023-03-31
Bank Overdrafts
Current
55 GBP2023-03-31
Bank Borrowings
Current
2,222,240 GBP2023-03-31
Trade Creditors/Trade Payables
Current
1,780,307 GBP2024-03-31
2,570,695 GBP2023-03-31
Amounts owed to group undertakings
Current
2,628,658 GBP2024-03-31
2,096,683 GBP2023-03-31
Corporation Tax Payable
Current
826,475 GBP2024-03-31
1,636,750 GBP2023-03-31
Taxation/Social Security Payable
Current
393,316 GBP2024-03-31
228,701 GBP2023-03-31
Other Creditors
Current
849,318 GBP2024-03-31
2,168,599 GBP2023-03-31
Accrued Liabilities/Deferred Income
Current
130,083 GBP2024-03-31
591,761 GBP2023-03-31
Creditors
Current
8,375,758 GBP2024-03-31
11,515,484 GBP2023-03-31
Bank Borrowings
Current, Amounts falling due within one year
2,222,240 GBP2023-03-31
Total Borrowings
Current, Amounts falling due within one year
2,222,240 GBP2023-03-31
Total Borrowings
2,222,240 GBP2023-03-31
Net Deferred Tax Liability/Asset
-4,684,416 GBP2024-03-31
-4,684,416 GBP2023-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
52,913 shares2024-03-31
52,913 shares2023-03-31
Par Value of Share
Class 1 ordinary share
0.0102023-04-01 ~ 2024-03-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
779,477 shares2024-03-31
779,477 shares2023-03-31
Par Value of Share
Class 2 ordinary share
0.0102023-04-01 ~ 2024-03-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
802,087 shares2024-03-31
802,087 shares2023-03-31
Par Value of Share
Class 3 ordinary share
0.0102023-04-01 ~ 2024-03-31
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
1,365,523 shares2024-03-31
1,365,523 shares2023-03-31
Par Value of Share
Class 4 ordinary share
0.0102023-04-01 ~ 2024-03-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
9,184 GBP2024-03-31
Between one and five year
16,837 GBP2024-03-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
26,021 GBP2024-03-31

Related profiles found in government register
  • PHARMACEUTICALS DIRECT LIMITED
    Info
    Registered number 03884028
    Old Station Road, Loughton IG10 4PL
    Private Limited Company incorporated on 1999-11-25 (25 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2024-11-25
    CIF 0
  • PHARMACEUTICALS DIRECT LIMITED
    S
    Registered number 03884028
    Haslers, Old Station Road, Loughton, Essex, England, IG10 4PL
    Limited Company in England And Wales Companies Registry, England And Wales
    CIF 1
child relation
Offspring entities and appointments
Active 1
  • PHARMACEUTICALS DIRECT (DISTRIBUTION) LTD - 2001-05-11
    Ambe House, Commerce Way, Edenbridge, Kent, United Kingdom
    Active Corporate (3 parents)
    Equity (Company account)
    96,223 GBP2024-03-31
    Person with significant control
    2016-04-06 ~ now
    CIF 1 - Ownership of shares – 75% or moreOE
    CIF 1 - Ownership of voting rights - 75% or moreOE
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.